Absence of inducible costimulator on alloreactive T cells reduces graft versus host disease and induces Th2 deviation (vol 106, pg 3285, 2005)

被引：0
|
作者：
Hubbard
机构：
来源：
BLOOD | 2006年 / 107卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：38 / 38
页数：1
相关论文
共 48 条
  • [21] INTESTINAL IMMUNE CONDITIONING WITH HELMINTHS EMPLOY HOST T HELPER 2 (TH2) PATHWAY TO INDUCE MIXED CHIMERISM AND REGULATE COLITIS ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE
    Truscott, Jamie
    Guan, Xiaoqun
    Liu, Weiren
    Li, Yue
    Beyatli, Sonay
    Metwali, Ahmed
    Urban, Joseph F.
    Elliott, David E.
    Blazar, Bruce R.
    Ince, Mirac N.
    GASTROENTEROLOGY, 2019, 156 (06) : S653 - S653
  • [22] Pharmacological Inhibition of Hsp90 Destabilizes the Histone Methyltransferase Ezh2 in Alloreactive T Cells and Reduces Graft-Versus-Host Disease While Retaining Anti-Leukemic Effects in Mice
    Huang, Qingrong
    He, Shan
    Tian, Yuanyuan
    Li, Changhong
    Gu, Yuting
    Chen, Pan
    Huang, Jiefang
    Liu, Yongnian
    Jin, Min
    Cao, Qi
    Reshef, Ran
    Zhang, Yi
    Zhang, Yanyun
    BLOOD, 2015, 126 (23)
  • [23] Influence of allogeneic Th-1 and Th-2 type CD4+ T cells on graft-versus-host disease and graft-versus-leukemia (GVL) effects in mice
    Zeis, M
    Uharek, L
    Glass, B
    Dreger, P
    Steinmann, J
    Schmitz, N
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 562 - 562
  • [24] Inducible Costimulator (ICOS) Up-Regulation on Activated T Cells in Chronic Graft-Versus-Host Disease After Dog Leukocyte Antigen-Nonidentical Hematopoietic Cell Transplantation: A Potential Therapeutic Target
    Sato, Masahiko
    Storb, Rainer
    Loretz, Carol
    Stone, Diane
    Mielcarek, Marco
    Sale, George E.
    Rezvani, Andrew R.
    Graves, Scott S.
    TRANSPLANTATION, 2013, 96 (01) : 34 - 41
  • [25] ATTENUATION OF GRAFT-VERSUS-HOST DISEASE AND GRAFT-REJECTION BY EX-VIVO IMMUNOTOXIN ELIMINATION OF ALLOREACTIVE T-CELLS IN AN H-2 HAPLOTYPE DISPARATE MOUSE COMBINATION
    CAVAZZANACALVO, M
    STEPHAN, JL
    SARNACKI, S
    CHEVRET, S
    FROMONT, C
    DECOENE, C
    LEDEIST, F
    GUYGRAND, D
    FISCHER, A
    BLOOD, 1994, 83 (01) : 288 - 298
  • [26] Transplantation of polarized type 2 donor T cells reduces mortality from graft-versus-host disease to minor histocompatibility antigens.
    Krenger, W
    Cooke, KR
    Crawford, JM
    Sonis, ST
    Simmons, R
    Pan, L
    Delmonte, J
    Karandikar, M
    Ferrara, JLM
    BLOOD, 1996, 88 (10) : 2692 - 2692
  • [27] Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism
    Foley, JE
    Jung, U
    Miera, A
    Borenstein, T
    Mariotti, J
    Eckhaus, M
    Bierer, BE
    Fowler, DH
    JOURNAL OF IMMUNOLOGY, 2005, 175 (09): : 5732 - 5743
  • [28] Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease
    Chen, Xiao
    Vodanovic-Jankovic, Sanja
    Johnson, Bryon
    Keller, Melissa
    Komorowski, Richard
    Drobyski, William R.
    BLOOD, 2007, 110 (10) : 3804 - 3813
  • [29] Skin-resident memory T cells are poised for systemic Th2/Th17-driven inflammation and may re-seed at distant sites during graft-versus-host disease
    Strobl, J.
    Gail, L.
    Kleissl, L.
    Pandey, Rv
    Krausgruber, T.
    Atzmueller, D.
    Wohlfarth, P.
    Bock, C.
    Rabitsch, W.
    Stary, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (10) : S149 - S149
  • [30] B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality (vol 125, pg 3335, 2015)
    Veenstra, R. G.
    Flynn, R.
    Kreymborg, K.
    BLOOD, 2016, 127 (24) : 3104 - 3104
12345